Winstgevend schreef op 13 december 2017 10:52:
UPDATE:
C1-Esterase Inhibitor (Human) Injection
Last Updated: November 29, 2017
Status: Current
C1-Esterase Inhibitor (Human) Injection
Products Affected - Description
Berinert intravenous injection, CSL Behring
500 unit, preservative-free vial (NDC 63833-0825-02)
Cinryze intravenous injection, Shire
500 unit, preservative-free vial (NDC 42227-0081-05)
Reason for the Shortage
CSL Behring has limited supply of Berinert due to increased demand.
Shire has resumed manufacturing of Cinryze and certain lots are available.
The subcutaneous dosage form of C1-esterase inhibitor (human) is unaffected by this shortage.
Available Products
There is insufficient supply for usual orderingMoet dit geen zwaar positief effect gaan krijgen op de omzetten in 2017 EN 2018 ?